Detalles de la búsqueda
1.
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist;
25(5): 422-430, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971318
2.
The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study.
J Geriatr Oncol;
15(4): 101765, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581957
3.
Executive function is associated with balance and falls in older cancer survivors treated with chemotherapy: A cross-sectional study.
J Geriatr Oncol;
14(8): 101637, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776612
4.
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol;
83(2): 145-151, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36272943
5.
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Cancer Immunol Res;
11(8): 1114-1124, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279009
6.
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
Clin Cancer Res;
28(5): 928-938, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34907080
7.
Integrative clinical and molecular characterization of translocation renal cell carcinoma.
Cell Rep;
38(1): 110190, 2022 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986355
8.
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
Mol Oncol;
15(9): 2330-2344, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33604999
9.
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Lung Cancer;
160: 78-83, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461400
10.
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
Nat Commun;
12(1): 808, 2021 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547292
11.
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
Cancer Cell;
37(6): 738-741, 2020 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32454025
12.
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma.
Eur Urol Oncol;
3(3): 372-381, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562048
13.
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
J Immunother Cancer;
8(2)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177176
14.
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma.
J Immunother Cancer;
8(1)2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066646
15.
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma.
Eur J Cancer;
135: 203-210, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599410
16.
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features.
J Clin Oncol;
38(1): 63-70, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721643
17.
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.
Cancer Immunol Res;
8(8): 1075-1084, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321774
18.
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.
Cancer Immunol Res;
6(4): 402-408, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437040
19.
Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.
J Immunother Cancer;
6(1): 5, 2018 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29353553
20.
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series.
J Immunother Cancer;
5(1): 66, 2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807048